✨ New Arrivals Just Dropped!Explore
Melatame-TX Tablet
Melatame-TX Tablet is a triple-action skin rejuvenation supplement formulated with L-Glutathione (Reduced), Tranexamic Acid, and L-Ascorbic Acid (Vitamin C). This advanced blend helps in skin brightening, reducing pigmentation, and enhancing overall skin tone. L-Glutathione acts as a potent antioxidant that neutralizes free radicals and promotes detoxification. Tranexamic Acid supports in reducing melanin synthesis and addressing hyperpigmentation, while Vitamin C boosts collagen production, promoting firmness and radiance. Regular use helps achieve clearer, healthier, and more luminous skin.
Select Pack
From $1.50
Original: $5.00
-70%Melatame-TX Tablet—
$5.00
$1.50More Images
Melatame-TX Tablet
Melatame-TX Tablet is a triple-action skin rejuvenation supplement formulated with L-Glutathione (Reduced), Tranexamic Acid, and L-Ascorbic Acid (Vitamin C). This advanced blend helps in skin brightening, reducing pigmentation, and enhancing overall skin tone. L-Glutathione acts as a potent antioxidant that neutralizes free radicals and promotes detoxification. Tranexamic Acid supports in reducing melanin synthesis and addressing hyperpigmentation, while Vitamin C boosts collagen production, promoting firmness and radiance. Regular use helps achieve clearer, healthier, and more luminous skin.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Melatame-TX Tablet is a triple-action skin rejuvenation supplement formulated with L-Glutathione (Reduced), Tranexamic Acid, and L-Ascorbic Acid (Vitamin C). This advanced blend helps in skin brightening, reducing pigmentation, and enhancing overall skin tone. L-Glutathione acts as a potent antioxidant that neutralizes free radicals and promotes detoxification. Tranexamic Acid supports in reducing melanin synthesis and addressing hyperpigmentation, while Vitamin C boosts collagen production, promoting firmness and radiance. Regular use helps achieve clearer, healthier, and more luminous skin.
